Another study also found that MCM3AP-AS1 expression was upregulated in OSCC, and the expression level of MCM3AP-AS1 was significantly correlated with clinical stage and lymph node metastasis, with a higher percentage of high MCM3AP-AS1 expression in patients with stage III/IV and positive lymph node metastasis [46]. The gene discussed is MCM3AP; the disease is metastatic malignant neoplasm in the lymph nodes.